Patent · US Active

Pharmaceutical composition of a papillomavirus inhibitor

US9670159B2 · kind B2 · utility

0Cited by
0References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 7, 2013
Grant dateJun 6, 2017
Priority date
Expiry dateMay 7, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/0034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a pharmaceutical composition including a compound of general formula (I) combined with a solvent and a viscosity-enhancing agent, as well as to the use thereof as a drug, in particular for treating and preventing infection with the papillomavirus, and to the method for preparing same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.